EWA
BNTC icon

EverSource Wealth Advisors’s Benitec Biopharma BNTC Stock Holding History

EverSource Wealth Advisors’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401 Sell
30
-183
-86% -$2.17K ﹤0.01% 4167
2026
Q1 		$2.27K Buy
+213
New +$2.47K ﹤0.01% 3601
2025
Q3 		– Sell
-148
Closed -$1.73K – 4334
2025
Q2 		$1.73K Buy
+148
New +$2.07K ﹤0.01% 3548

Other funds holding BNTC

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EverSource Wealth Advisors's BNTC Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Benitec Biopharma (BNTC) stake by 86% in Q2 2026, selling an estimated $2.17K and leaving 30 shares worth $401. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

EverSource Wealth Advisors first reported a position in BNTC in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.27K in Q1 2026. 13 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • EverSource Wealth Advisors held 30 shares of Benitec Biopharma worth $401 as of Q2 2026.
  • EverSource Wealth Advisors sold 183 Benitec Biopharma shares in Q2 2026, an estimated $2.17K.
  • Benitec Biopharma made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4167 holding.
  • EverSource Wealth Advisors first reported a position in Benitec Biopharma in Q2 2025 and has held it in 3 quarters since.
  • EverSource Wealth Advisors's Benitec Biopharma position peaked at $2.27K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.